N
NGM

Natixis’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Natixis’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-181,366
Closed -$288K – 1195
2024
Q1 		$288K Buy
+181,366
New +$269K ﹤0.01% 682

Natixis's NGM Position: Q2 2024 in Review

Natixis sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 181,366 shares — an estimated $288K sold.

Natixis first reported a position in NGM in Q1 2024 and held it in 1 quarter. The position peaked at $288K in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

  • Natixis reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Natixis sold 181,366 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $288K.
  • Natixis first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
  • Natixis's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $288K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Natixis's 13F filing for Q2 2024, filed 13 Aug 2024.